» Articles » PMID: 7975449

Microbiologic Contamination of Peripheral Blood Stem Cell Autografts

Overview
Journal Vox Sang
Specialty Hematology
Date 1994 Jan 1
PMID 7975449
Citations 5
Authors
Affiliations
Soon will be listed here.
Abstract

We have determined the incidence and clinical significance of positive microbiologic cultures in a series of 290 peripheral blood stem cell concentrates in 95 patients undergoing multiple apheresis procedures for autologous stem cell rescue. Specimens for bacterial cultures were obtained after processing of the autografts just prior to freezing. The incidence of microbial contamination was 4.5% (n = 13). The predominant pathogenic microorganism cultured was coagulase-negative Staphylococcus (n = 11). From 8 patients with contaminated leukapheresis products 6 underwent autologous stem cell transplantation. Five patients received 1-5 culture-positive stem cell concentrates without serious sequelae, whereas the sixth patient was autografted with noncontaminated leukapheresis products, 1 concentrate contaminated with Aspergillus fumigatus being not reinfused. No microorganism present in the stem cell autograft was recovered in vivo in the posttransplantation period, although fever as a sign of infection occurred in all but 1 patient. Peripheral blood stem cell collection and ex vivo processing for cryopreservation may result in microbiologic contamination. However, our data show that infusion of contaminated stem cell autografts does not play a significant role as a source for infections in the clinical setting of autologous stem cell rescue.

Citing Articles

Effects of storage temperature on hematopoietic stability and microbial safety of BM aspirates.

Hahn S, Sireis W, Hourfar K, Karpova D, Dauber K, Kempf V Bone Marrow Transplant. 2013; 49(3):338-48.

PMID: 24185589 DOI: 10.1038/bmt.2013.176.


Hematopoietic SCT with cryopreserved grafts: adverse reactions after transplantation and cryoprotectant removal before infusion.

Shu Z, Heimfeld S, Gao D Bone Marrow Transplant. 2013; 49(4):469-76.

PMID: 24076548 PMC: 4420483. DOI: 10.1038/bmt.2013.152.


Limiting the daily total nucleated cell dose of cryopreserved peripheral blood stem cell products for autologous transplantation improves infusion-related safety with no adverse impact on hematopoietic engraftment.

Khera N, Jinneman J, Storer B, Heimfeld S, OMeara M, Chauncey T Biol Blood Marrow Transplant. 2011; 18(2):220-8.

PMID: 21703976 PMC: 3204152. DOI: 10.1016/j.bbmt.2011.06.003.


Cryopreservation of hematopoietic stem cells.

Berz D, McCormack E, Winer E, Colvin G, Quesenberry P Am J Hematol. 2007; 82(6):463-72.

PMID: 17266054 PMC: 2075525. DOI: 10.1002/ajh.20707.


Autografting with blood progenitor cells: predictive value of preapheresis blood cell counts on progenitor cell harvest and correlation of the reinfused cell dose with hematopoietic reconstitution.

Schwella N, Siegert W, Beyer J, Rick O, Zingsem J, Eckstein R Ann Hematol. 1995; 71(5):227-34.

PMID: 7492625 DOI: 10.1007/BF01744372.